Abstract:Pulmonary hypertension (PH) is a complex, lethal vascular disease and currently has very limited treatment options with no cure. Severe pulmonary vascular remodeling and right ventricular (RV) hypertrophy in PH ultimately lead to RV failure. Endothelial dysfunction (ED) is demonstrated to play a key role in the initiation of PH. However, the pathogenic mechanisms leading up to ED remain unclear. We hypothesized that mitochondrial dysfunction (MD) in endothelial cells (EC) would produce a specific gene expression pattern in each EC subpopulation, revealing pathogenic pathways that trigger ED. Rats with the NFU1G206C mutation spontaneously develop PH, recapitulating the human disease in patients with multiple mitochondrial dysfunctions syndrome and PH. Transcriptomics was performed with the 10X Genomics kit on isolated single cell EC’s from WT and NFU1G206C rats. EC clustering was done with the Seurat V4 R package. The Database for Annotation, Visualization and Integrated Discovery (DAVID) identified enriched biological pathways. RV function was determined by echocardiography imaging (Vevo 3100 system). Echo results confirmed that NFU1G206C rats showed a spontaneous PH phenotype. Thirteen distinctive subpopulations of EC’s were identified in WT and NFU1G206C rats with UMAP and tSNE analysis, based on specific marker expressions such as alveolar capillary ECs (expressing ca4), small capillary ECs (fabp4), lymphatic ECs (prox1) and ECs regulating arteriogenesis (gja5) to ECs undergoing endothelial mesenchymal transition (EndMT) (acta2, encoding for α‐SMA). DAVID analysis of genes expressed in individual EC clusters showed heterogenous functions such as cell adhesion, inflammatory response, migration, and angiogenesis, highlighting the physiological relevance of EC’s. Cells were then classified as either senescent, quiescent, or proliferative, based on genes enriched in the respective pathways. We found that EC clusters of NFU1G206C rats significantly deviated from conventional gene expression profiles of WT clusters. The cluster1 of NFU1G206C rats showed an increase in senescence marker, lamb1 and decreased mki67. On the other hand, genes associated with proliferation were significantly increased in cluster2. We also identified EC’s with increased association of EndMT genes in cluster7. Most remarkably, in clusters 3, 5 and 9 of the NFU1G206C rats, we discovered a significant decrease in genes controlling cell adhesion and junction proteins, which could potentiate EC barrier dysfunction, an important contributor to PH pathobiology. These global aberrations from conventional EC functions could initiate pathobiological transformation. We demonstrate that EC functions are diverse and crucial for normal vascular function and maintenance. We also highlight that MD can shift the EC’s from their native to pathological states. Therefore, treatment approaches that attenuate MD or targets the specific changes leading up to ED would effectively control PH.

Role of mitochondrial PKD on right ventricular fibrosis under pulmonary hypertension

PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension

Abstract 4143932: Exploring P300/CBP as therapeutic approach for right ventricular dysfunction in PAH

Acquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension

Reduction in activity and abundance of mitochondrial electron transport chain supercomplexes in pulmonary hypertension-induced right ventricular dysfunction

Inhibition of MRTF-A Ameliorates Pathological Remodeling of the Pressure-loaded Right Ventricle

Proteomic and Phosphoproteomic Analysis of Right Ventricular Hypertrophy in the Pulmonary Hypertension Rat Model

Does Cell-Type-Specific Silencing of Monoamine Oxidase B Interfere with the Development of Right Ventricle (RV) Hypertrophy or Right Ventricle Failure in Pulmonary Hypertension?

Inhibitors of Mitochondrial Dynamics Mediated by Dynamin-Related Protein 1 in Pulmonary Arterial Hypertension

Skeletal muscle mitochondrial dysfunction precedes right ventricular impairment in experimental pulmonary hypertension

Right ventricular stiffening and anisotropy alterations in pulmonary hypertension: Mechanisms and relations to function

Abstract 15702: Role of the Drp-1 Receptors Mid49 and Mid51 in Regulating Fission and Cell Proliferation in Pulmonary Arterial Hypertension

Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension

Abstract 15168: The Role of Mitochondrial Fission Factor (MFF) and Increased Midzone Mitochondrial Fission in Pulmonary Arterial Hypertension: Implications for Proliferation, Mitophagy, and Apoptosis

Evaluation and Treatment of Endoplasmic Reticulum (ER) Stress in Right Ventricular Dysfunction during Monocrotaline-Induced Rat Pulmonary Arterial Hypertension

Role of Dynamin 2 in mitochondrial fission and cell cycle regulation: Dysregulation of a miR-124-3p-STAT3-DNM2-Drp1-RGCC pathway connects fission and cell proliferation in pulmonary arterial hypertension

Microvascular preservation and cardiomyocyte hyperplasia underlie adaptive right ventricular development in congenital heart disease-associated pulmonary arterial hypertension

ERK/Drp1‐dependent mitochondrial fission contributes to HMGB1‐induced autophagy in pulmonary arterial hypertension

Single‐Cell Sequencing in the Genetic Model of Mitochondrial Dysfunction Reveals Heterogeneity of Lung Endothelial Cells and Novel Targets in Pulmonary Hypertension

Comparative analysis of right ventricular metabolic reprogramming in pre-clinical rat models of severe pulmonary hypertension-induced right ventricular failure

Macrophage–NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension